Roche Czech Republic made a net profit of CZK 51.0 mil in 2015, down 46.3% when compared to the previous year. Historically, company's net profit reached an all time high of CZK 135 mil in 2013 and an all time low of CZK 16.8 mil in 2007.
This implies return on equity of 4.40% and return on invested capital of 2.65% in 2015. That is compared to 6.47% and 4.84% average seen in the last five years.
Since 2010, net profit of the firm increased by -67.1% or -19.9% a year on average.
As far as Roche Czech Republic's peers are concerned, Bayer Czech Republic generated ROE of 50.6% and ROCE of 29.0% in 2015 Amgen Czech Republic's profitability reached 18.4% and 36.6%, respectively..